Rejection in Solid Organ Transplantation

Clinical Transplantation Day - 27 November 2015 Parma (Italy)

An increasing number of sensitized patients at high risk for rejection undergo solid organ transplantation. Moreover even in the low risk categories, the availability of new diagnostic tools and heightened clinical awareness has increased the recognition of antibody and T-cell mediated rejections.

Finally the widespread use of protocol for calcineurin minimization in low risk patients has somewhat stopped the historical trend toward the reduction of the rate of acute T cell mediated rejection. Nonetheless, it is not always clear what are the best strategies to prevent rejection development and how rejection episodes should be treated in low as opposed to high risk patients.

The Course provides a comprehensive overview on all aspects of rejection in solid organ transplantation namely, immunology and pathology of rejection, risk prediction, optimal organ allocation to prevent rejection, the most appropriate immunosuppressive regimens in the low and high risk patients, when to stop anti-rejection therapy.

The event is organised jointly by EKITA and DESCARTES (a working group of ERA-EDTA), and was accredited by EACCME and assigned of 5 European CME Credits.

Registration is available online until 25th November.